Pharmaceutical and Specialty Pharmacy Service Companies
Listed below are companies associated with the mission of the Pulmonary Hypertension Association. These are for-profit companies which have interests in PH drugs, treatments and special services. These listings are not to be taken as endorsements of the companies.
PHA’s Scientific Leadership Council has authored treatment fact sheets about each of the therapies listed below.
Accredo Therapeutics
Accredo Therapeutics is a national network of pharmacies providing nursing and pharmacy services, and the only provider of all FDA-approved therapies to patients with pulmonary arterial hypertension. Accredo provides Tracleer, Revatio, Letairis, Adcirca, Ventavis, Tyvaso, generic epoprostenol sodium and they are the exclusive provider of Flolan.
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. is a subsidiary of a Swiss drug development company by the same name, which focuses on the endothelin. They are the developer of Tracleer (bosentan), an oral dual endothelin receptor antagonist. Actelion has also in-licensed Ventavis (inhaled iloprost) from Schering AG for the treatment of pulmonary arterial hypertension, an orphan indication, for the US market. Actelion's newest product is Veletri, epoprostenol for injection that is stable at room temperature.
Cané Medical Technology
Cané Medical Technology manufactures a mini pump for use with Remodulin.
CVS Caremark
CVS Caremark is a full-service provider for PAH therapies including Tracleer, Revatio, Letairis, Adcirca, Tyvaso, Ventavis and generic epoprostenol. The Caremark PAH Care Program focuses on the unique needs of individuals with PAH and carefully monitors patient care throughout the course of therapy. The company is staffed by a team of pharmacists, nurses, patient service representatives and reimbursement specialists.
CuraScript
CuraScript is a specialty pharmacy that dispenses special medications and related medical supplies that treat chronic illnesses. CuraScript works with physicians to encourage and educate their specialty patients on the therapies, side effects and importance of compliance to their medications. CuraScript is a provider of Tracleer, Revatio, Letairis, Adcirca, Tyvaso, Ventavis and generic epoprostenol sodium.
Fairview Specialty Pharmacy
Fairview Specialty Pharmacy provides personal medication management services for some pulmonary hypertension therapies, including Letairis (ambrisentan) and Revatio (sildenafil citrate).
Gilead Sciences
Gilead Sciences is the maker of Letairis (ambrisentan). Gilead develops pharmaceuticals for a variety of life-threatening illnesses, including cardiovascular diseases.
GlaxoSmithKline
GlaxoSmithKline are the makers of Flolan (epoprostenol).
Lilly
Lilly is the developer of Cialis (tadalafil). Tadalafil was approved for the treatment of pulmonary hypertension in May 2009. Lilly sold the rights to commercially develop tadalafil to United Therapeutics in late 2008.
Lung LLC
Lung LLC, a separately managed affiliate of United Therapeutics, is the maker of Tyvaso (inhaled treprostinil). Lung LLC is developing several pharmaceutical products, including a cell-based gene therapy solution for pulmonary hypertension (autologous cell-mediated eNOS) and a modified-release oral formulation of beraprost sodium.
Medtronic
Medtronic is a medical technology company that manufactures pumps for use with Remodulin.
Pfizer
Pfizer is the developer of Revatio (sildenafil citrate), an oral PAH treatment. An intravenous form of Revatio was approved in November 2009 for patients currently prescribed Revatio tablets but who are temporarily unable to take oral medication.
Pharmaceutical Research and Manufacturers Association (PhRMA)
Pharmaceutical Research and Manufacturers Association (PhRMA) is the leading association of research-based pharmaceutical and biotechnology companies. The Partnership for Prescription Assistance program (888-477-2669) is dedicated to assisting patients and physicians determine eligibility for available pharmaceutical support programs.
Philips Respironics
Philips Respironics is a medical equipment manufacturer specializing in sleep and respiratory equipment.
Smiths Medical
Smiths Medical is a medical equipment manufacturer that makes pumps for use with Remodulin and Flolan.
Teva Pharmaceuticals
Teva Pharmaceuticals, a generic pharmaceutical manufacturer, markets approximately 380 products. The company manufactures epoprostenol sodium for injection, along with a broad range of products in all major therapeutic categories.
United Therapeutics
United Therapeutics is a niche pharmaceutical/disease management company dedicated to the development and marketing of innovative therapies for serious lung diseases, with a strong focus on pulmonary hypertension. They are the makers of Adcirca (tadalafil) and Remodulin (treprostinil sodium).
PHA’s Corporate Committee
A number of the companies listed above are part of PHA’s Corporate Committee. Through this committee, the members work together toward solutions to a wide variety of issues, including raising public visibility of PH and supporting education needs of the patient and medical community. View a full list of Corporate Committee members